Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today the appointment of Pushkal Garg, M.D., to the position of Senior Vice President, Clinical Development. Dr. Garg has extensive experience in clinical development across a broad range of therapeutic areas. At Alnylam, he will join the existing development team and be responsible for managing the company’s clinical research, clinical operations, and biometrics functions.
